Dextromethorphan/quinidine (AVP-923) efficacy and safety for treatment of agitation in persons with alzheimer's disease: Results from a phase 2 study (NCT01584440)

Category Primary study
JournalAmerican Journal of Geriatric Psychiatry
Year 2015
This article has no abstract
Epistemonikos ID: 8fb66c56ec25e7eb8e60936366acb483bba691f5
First added on: Feb 06, 2025